那可丁
![那可丁 结构式](https://img.chemicalbook.com/CAS/GIF/912-60-7.gif)
那可丁 性质
熔点 | 221-223 °C(lit.) |
---|---|
储存条件 | 2-8°C |
溶解度 | 易溶于水和乙醇(96%)。水溶液呈微酸性;当溶液静置时,遇碱可能会沉淀。 |
颜色 | 晶体 |
Merck | 13,6752 |
EPA化学物质信息 | 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-[(5R)-5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl]-, hydrochloride, (3S)- (912-60-7) |
那可丁 用途与合成方法
Sigma opioid receptors Bradykinin Apoptosis
Noscapine (0-1000 μM; 0-96 hours; rat C6 glioma cells) treatment inhibits cell viability of rat C6 glioma in vitro in a dose- and time-dependent manner. Noscapine inhibits the viability of rat C6 glioma cells with an IC
50
of 250 μM at 72 hours.
Noscapine exposure causes abnormal S-phase reentry, increases mitotic arrest and results in excessive DNA accumulation.
Cylindromatosis increases the ability of noscapine to induce mitotic arrest and apoptosis. Cylindromatosis enhances the effect of noscapine on microtubule polymerization and promotes noscapine binding to microtubules.
Cell Proliferation Assay
Cell Line: | Rat C6 glioma cells |
Concentration: | 0 μM, 0.1 μM, 1 μM, 2 μM, 10 μM, 50 μM, 100 μM, 1000 μM |
Incubation Time: | 0 hours, 12 hours, 24 hours, 48 hours, 72 hours, 96 hours |
Result: | Inhibited cell viability of rat C6 glioma in vitro in a dose- and time-dependent manner. |
Noscapine (300 mg/kg; oral gavage; daily; for 15 days; athymic female mice) treatment reduces tumor growth in mice.
Animal Model: | Athymic female mice (nu/nu) (8-week-old) injected with rat C6 glioma cells |
Dosage: | 300 mg/kg |
Administration: | Oral gavage; daily; for 15 days |
Result: | Revealed a significant reduction of tumor volume. |
安全信息
危险品标志 | Xn,Xi |
---|---|
危险类别码 | 22 |
安全说明 | 36 |
危险品运输编号 | 1544 |
WGK Germany | 3 |
RTECS号 | NP7225000 |
F | 10 |
海关编码 | 2939.19.5000 |
危险等级 | 6.1(b) |
包装类别 | III |
毒性 | cyt-ham:fbr 60 mg/L ESKHA5 96,55,78 |